» Articles » PMID: 36184080

Microbial Metabolites As Ligands to Xenobiotic Receptors: Chemical Mimicry As Potential Drugs of the Future

Overview
Specialty Pharmacology
Date 2022 Oct 2
PMID 36184080
Authors
Affiliations
Soon will be listed here.
Abstract

Xenobiotic receptors, such as the pregnane X receptor, regulate multiple host physiologic pathways including xenobiotic metabolism, certain aspects of cellular metabolism, and innate immunity. These ligand-dependent nuclear factors regulate gene expression via genomic recognition of specific promoters and transcriptional activation of the gene. Natural or endogenous ligands are not commonly associated with this class of receptors; however, since these receptors are expressed in a cell-type specific manner in the liver and intestines, there has been significant recent effort to characterize microbially derived metabolites as ligands for these receptors. In general, these metabolites are thought to be weak micromolar affinity ligands. This journal anniversary minireview focuses on recent efforts to derive potentially nontoxic microbial metabolite chemical mimics that could one day be developed as drugs combating xenobiotic receptor-modifying pathophysiology. The review will include our perspective on the field and recommend certain directions for future research. SIGNIFICANCE STATEMENT: Xenobiotic receptors (XRs) regulate host drug metabolism, cellular metabolism, and immunity. Their presence in host intestines allows them to function not only as xenosensors but also as a response to the complex metabolic environment present in the intestines. Specifically, this review focuses on describing microbial metabolite-XR interactions and the translation of these findings toward discovery of novel chemical mimics as potential drugs of the future for diseases such as inflammatory bowel disease.

Citing Articles

Bacteria and Allergic Diseases.

Guryanova S Int J Mol Sci. 2024; 25(19).

PMID: 39408628 PMC: 11477026. DOI: 10.3390/ijms251910298.


Pregnane X Receptor Signaling Pathway and Vitamin K: Molecular Mechanisms and Clinical Relevance in Human Health.

Staudinger J, Mahroke A, Patel G, Dattel C, Reddy S Cells. 2024; 13(8.

PMID: 38667296 PMC: 11049418. DOI: 10.3390/cells13080681.


Analysis of metabolites in human gut: illuminating the design of gut-targeted drugs.

Gil-Pichardo A, Sanchez-Ruiz A, Colmenarejo G J Cheminform. 2023; 15(1):96.

PMID: 37833792 PMC: 10571276. DOI: 10.1186/s13321-023-00768-y.

References
1.
Ramakrishnan S, Zhang H, Ma X, Jung I, Schwartz A, Triner D . Intestinal non-canonical NFκB signaling shapes the local and systemic immune response. Nat Commun. 2019; 10(1):660. PMC: 6368617. DOI: 10.1038/s41467-019-08581-8. View

2.
Fukata M, Shang L, Santaolalla R, Sotolongo J, Pastorini C, Espana C . Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis. 2011; 17(7):1464-73. PMC: 3117047. DOI: 10.1002/ibd.21527. View

3.
Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A . Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep. 2014; 7(1):12-8. DOI: 10.1016/j.celrep.2014.02.032. View

4.
May C, Bellomo R, Lankadeva Y . Therapeutic potential of megadose vitamin C to reverse organ dysfunction in sepsis and COVID-19. Br J Pharmacol. 2021; 178(19):3864-3868. PMC: 8239596. DOI: 10.1111/bph.15579. View

5.
Illes P, Krasulova K, Vyhlidalova B, Poulikova K, Marcalikova A, Pecinkova P . Indole microbial intestinal metabolites expand the repertoire of ligands and agonists of the human pregnane X receptor. Toxicol Lett. 2020; 334:87-93. DOI: 10.1016/j.toxlet.2020.09.015. View